Prognostic Impact of Squamous Cell Carcinoma Antigen During Neoadjuvant Chemotherapy for Patients With Esophageal Squamous Cell Carcinoma Treated With Minimally Invasive Esophagectomy
For patients with esophageal squamous cell carcinoma treated with NAC followed by MIE, a high SCC level prior to NAC which was also high after NAC was an independent prognostic factor and might contribute to deciding the need for adjuvant therapy.
Authors
- Taro Ikeda (ORCID: https://orcid.org/0000-0002-9202-3482)
- Hiroshi Hasegawa
- Yoshihiro Kakeji (ORCID: https://orcid.org/0000-0002-2727-0241)
- Ryuichiro Sawada
- Shingo Kanaji
- Naoki Urakawa (ORCID: https://orcid.org/0000-0002-9154-4972)
- Takeru Matsuda (ORCID: https://orcid.org/0000-0002-9541-856X)
- Taro Oshikiri
- YASUHUMI KOTERAZAWA
- Kimihiro Yamashita
- Hironobu Goto (ORCID: https://orcid.org/0000-0002-4337-5529)
- Hitoshi Harada (ORCID: https://orcid.org/0000-0002-9551-1510)
- R Torigoe (ORCID: https://orcid.org/0009-0006-5679-5465)
Institutions
- Ehime University (JP)
- Kobe University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-01
- DOI
- https://doi.org/10.21873/anticanres.17374
- Citations
- 2
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.15